Press releaseGlobe Newswire
Adlai Nortye
ANL · NASDAQ
$10.58+$0.00 (+0.00%)TodayMarket closed ·
Prev close $10.58
Latest news
- Press releaseGlobe Newswire
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
- Press releaseGlobe Newswire
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
- Press releaseGlobe Newswire
Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
- Press releaseGlobe Newswire
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia
- Press releaseGlobe Newswire
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025
- Press releaseGlobe Newswire
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
- NewsAvi Kapoor
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
- NewsAvi Kapoor
TeraWulf, BRP And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- Press releaseGlobe Newswire
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open
- Press releaseGlobe Newswire
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
- Press releaseGlobe Newswire
Adlai Nortye to Participate in Upcoming Investor Conferences
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.